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Abstract 
Parkinson’s disease (PD) is characterized clinically by the impaired ability to execute smooth, 
controlled movements, and pathologically by a lack of striatal dopamine. However, the role that 
dopamine plays in the striatum remains poorly understood. Previous experiments using striatal 
dopamine receptor blockade or dopaminergic denervation have demonstrated progressive 
impairment in conditioned behaviors, suggesting a role for dopamine in motor learning. Other 
evidence, however, suggests that dopamine is critical for motivating acute motor performance. In 
this study, I trained rats to a high degree of accuracy in a choice reaction-time task and then 
performed focal dopamine denervation in dorsolateral (“sensorimotor”) striatum. After 
dopaminergic lesioning, the rats initially performed the task at baseline efficiency. Consistent 
with a “learning” model of dopamine function, task performance became gradually impaired 
with task repetition. I then attempted to rescue task performance via systemic administration of 
levodopa. Reaction times dropped to baseline levels on the first day of levodopa administration, 
and they continued to shorten with each day of practice. These low reaction times persisted into 
the third week even without acute dopamine replacement. These results suggest that striatal 
dopamine has roles in motor learning and acute motor performance. Further investigation is 
required to understand how these functions interact in normal motor learning and control. 
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TIME-COURSE OF MOTOR DEFICITS  3 
	  
Introduction 
Parkinson’s disease (PD) is a neurodegenerative syndrome characterized by bradykinesia, 
rigidity, postural instability, and resting tremor. The motor deficits of PD have been traced to the 
progressive death of dopaminergic neurons in the substantia nigra pars compacta (SNc), which 
primarily projects to the striatum. It is well established that the motor deficits of PD are related to 
insufficient dopamine levels in the striatum (Hornykiewicz, 2010), which is the primary input 
nucleus of the basal ganglia. Therefore, it was widely believed for years that the primary role of 
dopamine in the basal ganglia is to allow smooth and well-coordinated movement. 
  More recently, however, empirical evidence has led to new hypotheses for the role of 
dopamine in normal physiology. Dopamine neurons had been observed to fire transiently in 
response both to conditioned and unconditioned visual stimuli (Schultz, 1993). This and similar 
studies imply a “reward” function for striatal dopamine which may play a causal role in certain 
forms of learning (Schultz, 2002). That is, when an unexpected positive event occurs, dopamine 
pulses signal to the striatum that the actions leading up to that event are worth repeating in the 
future. These bursts of phasic dopamine follow both unanticipated rewards and reward-
predicting stimuli (Schultz, 2002). It has been suggested that phasic pulses of dopamine release 
serve as a mechanism for synaptic modification, encoding a reward prediction error (RPE) in a 
reinforcement-learning model of the striatum (Glimcher, 2011; Oyama et al., 2010). Other 
theories suggest that, instead of “liking” or learning, dopamine causes “wanting” of rewards 
(Berridge, 2007). In this construct, dopamine levels should impact performance in the current 
trial; under “learning” models, dopamine levels during the current trial should impact future task 
performance. 
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  A role for dopamine in motor learning provides an alternative explanation for the motor 
deficits observed in PD. Following dopamine depletion, rats are able to perform an operant task 
normally, at least initially (Dowd & Dunnett, 2004). Only with repeated trials does their 
performance deteriorate. It was later suggested that deficits in movement initiation and execution 
might be downstream of the reward signal from phasic dopamine release (Dowd and Dunnett, 
2007).  Intrastriatal dopamine-receptor blockade has supported this claim, showing impaired task 
execution in an experience-dependent manner (Stoetzner, 2011). Therefore, a lack of dopamine 
in the striatum could essentially extinguish motor programs in a process that has been described 
as “extinction mimicry” (Wise, 1982). This mechanism could not only account for the 
bradykinetic symptoms of PD, but also the sustained improvement in the motor function of PD 
patients observed long after a levodopa dose has been eliminated from the body, clinically 
known as the long-duration response (LDR, Anderson & Nutt, 2011). This effect is in contrast to 
the rapid improvement in motor function observed after a single levodopa dose in PD, known as 
the short-duration response (SDR). 
Complementing these behavioral results are physiological data suggesting cellular and 
molecular mechanisms for dopamine in striatal synaptic plasticity. In particular, the so-called “3-
factor rule” suggests that synaptic plasticity at corticostriatal synapses is regulated by dopamine 
levels (Shen et al., 2008). Striatal projection neurons can be subdivided into 2 types: D1 
receptor-expressing neurons and D2 receptor-expressing neurons, which project via the direct 
pathway and indirect pathway, respectively (Albin et al., 1989). Since D2 receptors have a higher 
binding affinity for dopamine than D1 receptors, it follows that D1 receptors may respond to 
phasic dopamine increases, whereas D2 receptors may respond to phasic dopamine decreases. 
Under the reinforcement-learning model, increases in phasic dopamine release associated with 
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positive RPEs would alter the direct pathway via D1 receptors. Dopamine depletion in PD could 
oppositely play a role in mediating the enhancement of the indirect pathway, giving rise to the 
hypokinetic movement disorder. During a levodopa drug holiday, synaptic connections—
possibly representing specific motor programs—may persist until gradually degraded by the 
extinction mimicry process (Beeler, 2011), due to dysregulated dopamine-mediated synaptic 
plasticity. 
  In the current study, I explored the relationship between motor parkinsonism and 
dopamine’s role in reward processing by analyzing the development of motor impairments in 
dopamine-depleted rats. I first trained several rats to a high performance level on a lateralized 
choice task. These rats were then unilaterally dopamine-depleted in dorsolateral (“sensorimotor”) 
striatum. In order to investigate the time-course of motor deficit development and recovery, they 
were subsequently re-tested on the choice task, with and without levodopa treatment. In addition 
to the operant tasks, spontaneous motor deficits were investigated using the limb-use asymmetry 
(LUA) test, a commonly used metric of motor performance in unilaterally dopamine-depleted 
rodents. I hypothesized that spontaneous motor deficits would develop quickly, but motor 
deficits in the operant task would only gradually emerge with practice. Furthermore, I anticipated 
that the time-course of recovery given levodopa administration would show a similar gradual 
improvement. Such results would be compelling evidence in favor of the extinction mimicry 
model of PD. 
Method 
Overview 
  Animals were trained for several weeks on a lateralized choice task, advancing through 
progressive stages contingent upon task performance. Baseline tests were conducted at the most 
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difficult level for five days before the animals were lesioned with 6-OHDA in dorsolateral 
striatum (Figure 1). LUA testing occurred once during baseline testing, every three days for two 
weeks after the lesion, and then continued daily through the remainder of the experimental 
period. Two weeks following the lesion, animals were re-tested on the choice task daily for 
seven days. Testing continued for the next seven days, but this time after systemic administration 
of levodopa. Finally, testing for the next seven days occurred in the absence of levodopa. Lesions 
were verified post-mortem by immunohistochemical staining for tyrosine hydroxylase (TH). 
  Animal Care. All procedures were approved by the University of Michigan’s Committee 
on Use and Care of Animals. Twelve adult male Long-Evans rats (350-550g) were group-housed 
on a 12/12 hr reverse light/dark cycle. Testing occurred at approximately the same time daily 5-6 
days/week for each animal for 1 hour, during the dark phase. Animals were food-restricted to 15 
g of chow per day to motivate them for the food reward. Access to food was ad libitum for the 
first week after surgery. Weight was measured weekly to ensure that at least 90% of predicted 
free-feeding weight was maintained. 
Behavioral Experiment 
  Operant Training and Testing. Training and test sessions occurred in an enclosed 
operant chamber, containing 5 horizontally adjacent nose-poking portals along a slightly curved 
wall (Figure 2). Each portal contained a yellow LED and IR sensor. The opposite wall housed a 
well that dispensed fruit-punch flavored sucrose pellets (45 mg each, obtained from TestDiet, 
Richmond, IN; Item # 5TUT) as a food reward. 
  The task first required a nose-poke into a central lit port with a hold time randomly 
chosen from a uniform distribution (750 to 1250 ms). Next, either a 1000 Hz or 4000 Hz 
auditory cue was given, which signaled that the rat should swiftly nose-poke the left or right 
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adjacent portal, respectively. Each correct trial was rewarded with a sucrose food pellet, followed 
by a variable timeout period (15-25 seconds); each incorrect trial went directly to the timeout 
period with no reward. During the training period, animals advanced 9 difficulty levels, which 
progressively shaped behavior by decreasing the length of time the rats had to respond. Rats 
were advanced when they were correct on more than 80% of trials with less than 10% invalid 
trials (poking the wrong port to initiate a trial or not waiting for the tone). Reaction time (RT) 
was defined as the interval between the cue and exiting the initial nose-port. Movement time 
(MT) was defined as the subsequent interval between exiting the initial nose-port and entering 
the adjacent nose-port. Accuracy was defined as the number of rewarded trials divided by the 
total number of completed trials (that is, trials in which a side-port was poked). RT, MT, and 
accuracy were calculated independently for trials cued for movement ipsilateral and contralateral 
to the lesions. 
  Dopaminergic Lesions. A commonly used neurotoxic model of PD involves 6-
hydroxydopamine (6-OHDA) infusion into the nigrostriatal system. 6-OHDA enters neurons via 
catecholamine transporters, and is therefore selective for catecholaminergic neurons. Once inside 
the cells, it is oxidized to produce toxic free radicals, leading to cell death. The dopaminergic 
system may be lesioned by 6-OHDA infusion directly into dopaminergic nuclei (i.e. SNc), 
projection pathways (i.e. the medial forebrain bundle – mfb), or terminal fields of dopaminergic 
projections (i.e. the striatum). 
  In this experiment, 3 µL of 5.0 µg/µL 6-OHDA was infused into dorsolateral striatum. 
After the infusion, the cannula was left in place for 2 minutes to allow for diffusion of the drug. 
Half of the animals were randomly assigned to the left hemisphere and the other half to the right 
hemisphere. Infusion coordinates were A-P +0.5 mm and M-L +/- 3.5 mm relative to bregma, 
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and D-V 3.5 mm relative to the brain surface (Figure 3). An intraperitoneal (IP) injection of 25-
mg/kg desipramine was given 0.5 h prior to infusion to prevent 6-OHDA uptake into 
noradrenergic neurons. Animals were given two weeks to recover from surgery and to allow 
their lesions to stabilize before beginning testing on the operant task. 
  Limb-Use Asymmetry (LUA) Testing. The LUA test, also commonly known as the 
cylinder test, takes advantage of a rodent’s instinctive response to explore a novel environment. 
When placed in a clear plastic cylinder, a rodent explores by rearing up on its hind legs and using 
its forelimbs to support its body weight against the enclosing wall. Spontaneous forelimb use is 
evaluated by recording every independent instance of a weight-supporting wall touch—the paw 
must be completely stretched and all digits should be in contact with the glass in order to be 
counted (Cenci & Lundblad, 2007). It is expected that unilaterally dopamine-depleted rodents 
will execute fewer touches with the limb contralateral to their lesion. The LUA score was 
calculated as the proportion of contralateral touches out of the total number of touches; a score of 
0.5 therefore indicates no limb use asymmetry. Each LUA test lasted five minutes and occurred 
every 3 days after the lesion for 2 weeks, then daily preceding testing in the operant task, as 
described below. 
  Drug Administration. Test sessions began 14 days after 6-OHDA infusion. Each session 
was preceded by an IP injection of saline or levodopa/benserazide 35 minutes prior to the task. 
Levodopa is a dopamine precursor that can cross the blood-brain barrier and is subsequently 
converted into dopamine via dopa-decarboxylase in dopaminergic neurons. Benserazide, a dopa-
decarboxylase inhibitor that cannot cross the blood-brain barrier, is co-administered with 
levodopa to prevent unwanted levodopa conversion elsewhere in the body. This both preserves 
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levodopa so that it can enter the brain and prevents systemic side effects from the peripheral 
conversion of levodopa to dopamine. 
  The drug administration schedule consisted of three periods as follows: saline during the 
first week (“Saline 1”), levodopa/benserazide during the second week (“Levodopa”), and saline 
during the last week (“Saline 2”). 30 minutes after the injection, LUA testing occurred for 5 
minutes, followed immediately by testing in the operant task.  
  Histology. After the experiments, each animal was deeply anesthetized and transcardially 
perfused with 4% para-formaldehyde (PFA). Their brains were stored in 4% PFA for a period of 
18 - 24 hours before transfer to a 30% sucrose solution in 1x phosphate buffered saline (PBS) for 
cryopreservation. Brains were then sliced on a cryostat at 50 µm for both Nissl and TH staining. 
The final coordinates of the cannulae were confirmed by image analysis and mapping onto a 
standard rat brain atlas. 
  Statistical analysis. Behavioral analysis was performed using a general linear model, 
using SPSS Statistics 19 (IBM, Inc.) and MATLAB R2010b (The Mathworks, Inc.). The MT and 
RT data were standardized by subtraction of the average baseline performance of an individual 
animal from its performance on every test session. Two-factor ANOVA tests were utilized to 
assess differences in several behavioral responses for the choice task and LUA scores (factors: 
drug period and movement direction relative to lesion). Paired t-tests were utilized to assess 
differences between individual testing sessions.	  
Results 
  Histology. TH straining confirmed that some animals had substantial lesions, while other 
animals had relatively weak lesions. The locations of the cannulae were consistently targeted in 
the dorsolateral striatum, confirmed by Nissl stained sections. Out of a total of fifteen tested 
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animals, six animals had weak lesions and were therefore excluded from analysis (see Appendix). 
All the animals included in the final analysis performed a similar number of valid trials 
throughout all three drug periods (Figure 4).  
  Saline 1 Period. The behavioral choice data were segregated into contralaterally and 
ipsilaterally directed trials relative to the lesion site. Throughout the Saline 1 period, contralateral 
behavior shows significant deficits in comparison to baseline performance. Specifically, 
contralateral RT gradually increases with practice (Figure 6). Indeed, there is no significant 
difference in contralateral RT between the first test session of Saline 1 when compared to 
average baseline performance; t(8) = -0.8510, p = 0.4195. A two-factor analysis of variance 
tested the effects both of drug period and movement direction relative to the lesion. Performance 
during Saline 1 sessions showed a significantly higher RT than baseline performance, when 
comparing effects of drug period [F(7,56) = 4.597, p = 0.030] and direction [F(1,8) = 6.726, p = 
0.032]. Contralateral accuracy immediately declines and remains fairly stable (Figure 7). Two-
factor ANOVA similarly showed a significantly lower accuracy than baseline performance, 
when comparing effects of drug period [F(7,56) = 2.368, p = 0.034] and direction [F(1,8) = 5.331, 
p = 0.049]. Ipsilateral and contralateral MT remained at similar levels during all periods of 
testing (Figure 5). The gradual learning-like effect observed in RT is suggestive of the extinction 
mimicry model of PD. An alternative interpretation, however, is that the dopaminergic lesions 
progressed during the testing period.  
  Limb-use Asymmetry (LUA). The LUA behavioral data were used to evaluate if the 
gradually increasing RT might be explained by continued progression of the dopaminergic loss. 
Within 6 days of infusion, the rats showed a strong ipsilateral limb-use preference (Figure 8). 
These data suggest that the lesions develop quickly and stabilize during the post-operative period. 
TIME-COURSE OF MOTOR DEFICITS  11 
	  
The LUA scores remain strongly asymmetric until levodopa treatment, which gradually rescues 
the values back to baseline levels. These levels once again decline during the Saline 2 period. 
Single-factor ANOVA suggests a significant difference between 0.5—a perfectly symmetric 
score—compared to every subsequent test [F(25,104) = 1.718, p = 0.031]. These results suggest 
that the dopaminergic lesions were stable prior to post-lesion testing on the operant task, and 
support an extinction-like effect for the decline in task performance with repeated practice. 
  Levodopa Drug Period. The levodopa drug period showed a rapid, dramatic 
improvement, restoring performance back to baseline levels as measured by both accuracy and 
RT (Figures 6, 7). There was no significant difference between in contralateral RT between the 
first test session of the levodopa drug period and baseline performance; t(8) = -1.1835, p = 
0.2706. Comparing baseline performance to the levodopa drug period, 2-factor ANOVA reveals 
a non-significant change in RT, considering factors of drug period [F(7,56) = 0.798, p = 0.593] 
and direction [F(1,8) = 0.221, p = 0.651]. The decrease in RT progresses throughout the 
levodopa drug period, with a significant difference between the first and last sessions of the drug 
period; t(8) = 2.6445, p = 0.0295. Accuracy shows a similar recovery back to baseline levels, 
considering factors of drug period [F(7,56) = 0.798, p = 0.593] and direction [F(1,8) = 3.883, p = 
0.084]. This acute rescue in motor behavior is analogous to the SDR. 
  Saline 2 Period. Behavior during Saline 2 revealed a delayed, but gradual increase in RT 
and a corresponding decrease in contralateral accuracy (Figure 6, Figure 7). Comparing baseline 
performance to the Saline 2 period, 2-factor ANOVA reveals a non-significant change in RT, 
considering factors of drug period [F(7,56) = 0.627, p = 0.601] and direction [F(1,8) = 0.014, p = 
0.908]. This non-significant change verifies recovery from the motor deficits experienced during 
the Saline 1 period. Accuracy shows a similarly sustained recovery back to baseline levels, 
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considering factors of drug period [F(7,56) = 0.680, p = 0.509] and direction [F(1,8) = 0.836, p = 
0.387].  This learning effect can cautiously be interpreted as analogous to the LDR. 
Discussion 
  There are 3 primary results from these experiments. First, I demonstrated that unilateral 
dopamine depletion in dorsolateral (sensorimotor) striatum is sufficient to impair performance on 
a conditioned choice RT task. Second, I found that—despite early deficits in spontaneous limb 
use—motor performance on a conditioned task declines in a gradual, experience-dependent 
manner. Third, acute motor performance on the conditioned choice task can be rescued to 
baseline levels by systemic dopamine replacement, though there was also an experience-
dependent decrease in RT with repeated levodopa exposure. Together, these results suggest that 
dopamine in the dorsolateral striatum plays a role in both motor learning and acute motor 
performance. 
  The Role of Dopamine in Dorsolateral Striatum. Previous studies have demonstrated 
that unilateral 6-OHDA infusions across the entire striatum are sufficient to significantly impair 
motor performance in an instrumental learning task (Dowd & Dunnett, 2005). In order to further 
disentangle the role of dopamine in learning, the infusions in this experiment were targeted to 
produce focal lesions limited to dorsolateral striatum. I demonstrated that dopamine depletion in 
dorsolateral striatum alone is indeed sufficient to impair motor performance in a conditioned 
choice RT task. 
  The dorsolateral striatum seemed a likely lesion candidate to impair task performance 
based on its functional implications and projection patterns. Substantial evidence has long 
suggested that dorsal striatum is important in learning and memory (Devan & White, 1999), but 
recent findings have revealed that dorsolateral striatum is necessary for stimulus-response 
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learning and habit formation (Featherstone & McDonald, 2005). It participates in cortical-basal 
ganglia loops, principally receiving input from primary motor cortex and passing its output back 
to primary motor cortex via the substantia nigra, pars reticulata and thalamus (Haber et al., 2006). 
It follows that a lesion in this small structure is likely to disrupt critical motor outputs. Indeed, 
dopamine loss in clinical Parkinsonism occurs first and most prominently in dorsolateral striatum 
(McCallum et al., 2005). 
  Motor Performance Versus Motor Learning. Parameters of motor performance from 
the first test session after the dopaminergic lesion were nearly identical to baseline performance 
levels. The subsequent deficit in contralateral RT seems to be an experience-dependent learning 
effect. Previous unilateral 6-OHDA experiments have also demonstrated this progressive motor 
deficit, which closely mirrors the behavior of unlesioned control animals that simply stop 
receiving a food reward (Dowd & Dunnett, 2007). Recent findings in our laboratory also show 
similar gradual deficits, using a similar task under dopamine receptor blockade in dorsolateral 
striatum (Stoetzner, 2011). Furthermore, while task performance was largely restored to baseline 
performance on the first “levodopa” day, repeated levodopa doses further modified task 
performance. Finally, Together, these results are consistent with a role for dopamine in motor 
learning. 
  Acute Motor Performance. Systemic levodopa rescued choice task performance to 
baseline levels during the first “levodopa” session. This finding seemingly contradicts the 
reinforcement-learning model for striatal dopamine, due to the rapid improvement in both RT 
and accuracy from the very first day of levodopa administration. In fact, this acute effect closely 
resembles the clinical short-duration response (SDR), which is characterized by a rapid 
improvement in motor function that typically lasts approximately 3-4 hours after a single dose of 
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levodopa. The onset and offset of the SDR parallels the rise and fall of serum levodopa levels 
(Marin et al., 2007), supporting a role for dopamine in acute motor performance. 
  The incentive salience hypothesis, an alternative explanation for the role of striatal 
dopamine in the nigrostriatal circuit (Berridge, 2007), could account for this acute motor rescue. 
Dopamine is hypothesized to enhance the “wanting” component of motivation in a state-
dependent manner. After repeated extinction trials in a self-administration study, conditioned 
behavior was acutely rescued by reinstating dopaminergic drug (Stretch & Gerber, 1973). This 
effect is similar to the SDR, and it can be reconciled with the extinction mimicry model through 
the state-dependent presence of dopamine. In this respect, the extinction mimicry model does 
function like true extinction: previously conditioned behavior can be reinstated quickly, simply 
by restoring the reward (Wise, 2009). 
  LDR as Extinction Mimicry. In both the Saline 1 and Saline 2 periods, there is a 
sustained level of motor performance after dopamine loss, followed by gradual deterioration. 
Lacking all dopamine in dorsal striatum, the PITx3 genetic knockout mouse model also shows 
sustained sensorimotor improvement after a levodopa drug holiday (Beeler, 2010). It was 
similarly demonstrated that while dopamine is necessary for maintenance of motor function, 
animals could still perform an instrumental task at the same level immediately before and after 
dopamine-depletion (Dowd & Dunnett, 2005). The sustained effect common to these 
experiments may be analogous to the LDR, clinically observed in PD patients, in which the 
motor benefits of dopamine persist long after the elimination half-life of levodopa. 
  The LDR remains a poorly understood phenomenon, but the effect appears similar to the 
extinction mimicry process—perhaps by the gradual extinction of overtrained motor behavior. In 
the present experiment, it is possible that the synaptic weights representing motor programs are 
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sculpted both by positive RPEs during the Levodopa drug period and by negative RPEs during 
the Saline 2 period. However, the ratio of negative to positive RPEs and the magnitude of their 
effects on synaptic plasticity could potentially explain the LDR. Positive RPEs typically have a 
longer lasting maintenance effect than the degradation effects of negative RPEs, based on 
bidirectional Hebbian plasticity (Shen et al., 2008). Therefore, relatively few positive RPEs 
could counter the effect of more negative RPEs. Synaptic connections relevant to the task 
performance therefore may persist into the Saline 2 period, slowing the degradation process. 
  Dopamine-replacement-mediated RPE signaling could provide a cellular mechanism for 
the LDR. Interestingly, D2 dopamine receptor agonists can induce an LDR comparable to 
levodopa (Nutt & Carter, 2000). Because they have a higher binding affinity for dopamine, D2 
receptors are principally occupied by basal dopaminergic tone. In normal physiology, a negative 
RPE may be encoded by an acute decrease in dopamine, resulting in fewer occupied D2 
receptors and activation of the indirect (“No-Go”) pathway. However, the constitutively low 
levels of striatal dopamine in PD change this communication—pathologically vacant D2 
receptors permanently activate the indirect (“No-Go”) pathway instead, giving rise to the 
hypokinetic movement disorder. It follows, then, that D2-receptor agonist administration may 
protect against the detection of negative RPEs, thus creating the LDR. Dopamine agonist-
induced impulse control disorders may share a similar mechanism, in which susceptible patients 
are unable to process negative consequences of their actions. 
  In summary, this study suggests a link between “extinction mimicry” described in animal 
models of dopamine depletion and the bradykinesia associated with Parkinson’s disease. I have 
demonstrated that dopamine signaling in the dorsolateral striatum has roles in both 
reinforcement-learning and motor performance. These effects occur at different time-scales that 
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are analogous to the LDR and SDR, respectively. Further work is needed to more clearly dissect 
the roles of D1 (direct pathway) vs. D2 (indirect pathway) dopamine receptors in motor learning 
vs. motor performance. As the link between dopamine and the LDR becomes more clearly 
defined, revised therapeutic strategies can potentially maximize the clinical benefit of the LDR in 
PD patients. 
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Figure 1. Timeline of Experimental Design for a Single Animal. Animals were trained to 
criterion (see text), and baseline performance was recorded for 5 days on the choice task. 
Animals were then given a unilateral infusion of 6-OHDA, lesioning the dorsolateral striatum. 
They were evaluated on the LUA test every 3 days for the first two weeks after lesioning. 
Beginning two weeks after these lesions, animals were re-tested on the choice task daily for 21 
days after administration of either saline or levodopa/benserazide. 
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Figure 2. Choice task schematic, adapted from Gage et al, 2010. (a) Rat receiving reward for 
completing a correct trial in the operant chamber. (b) Schematic of the choice task. (1) One of 
the three center nose-poke ports lights up. (2) Rat pokes the lit port and holds for a variable 
interval. (3) 1 or 4 kHz pure tone instructs the animal to move left or right, respectively. (4) 
“Choice” occurs as rat pulls its nose out of the initially lit nose port. (5) Rat nose-pokes the 
correct adjacent port, as indicated by the cue tone pitch. (6) Rat exits the second port. (7) Rat 
receives sucrose pellet reward at the back of the operant chamber. RT = reaction time, MT = 
movement time. 
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Figure 3. Dorsolateral striatal lesion. (a) Schematic illustrating the positioning of the cannula in 
the dorsolateral striatum. Figure provided by Dr. Daniel K. Leventhal. (b) Immunohistologic 
sample showing unilateral dopaminergic lesions via anti-tyrosine hydroxylase staining.  
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Figure 4. Mean Number of Trials per Session. The rats performed similar numbers of trials 
across experimental conditions. Baseline performance occurred between days -5 to -1. Saline 1 
performance occurred between days 14 to 20. Levodopa performance occurred between days 21 
to 27. Saline 2 performance occurred between days 28 to 34. Error bars indicate standard error in 
the mean. 
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Figure 5. Mean-subtracted Movement Time (MT). Movements have been segregated by 
direction of movement relative to the lesioned hemisphere (ipsilateral vs. contralateral). The MT 
(ipsilateral and contralateral) data were standardized by mean-subtraction of the average baseline 
performance of an individual animal from its performance on every test session. Error bars 
indicate standard error in the mean. 
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Figure 6. Mean-subtracted Reaction Time (RT). Movements have been segregated by direction 
of movement relative to the lesioned hemisphere (ipsilateral vs. contralateral). The RT 
(ipsilateral and contralateral) data were standardized by mean-subtraction of the average baseline 
performance of an individual animal from its performance on every test session. Error bars 
indicate standard error in the mean. Hash marks indicate a significant difference from baseline 
performance, considering both factors of drug period and movement direction. Asterisks indicate 
a significant difference between baseline performance and a particular testing session for 
contralateral movement. 
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Figure 6. Mean Accuracy. Movements have been segregated by direction of movement relative 
to the lesioned hemisphere (ipsilateral vs. contralateral). Error bars indicate standard error in the 
mean. Hash marks indicate a significant difference from baseline performance, considering both 
factors of drug period and movement direction. 
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Figure 8.  Mean Limb-use Asymmetry (LUA) scores. A score of 0.5 indicates completely 
symmetrical use of forelimbs, a score of 0 indicates a complete favor of the ipsilateral forelimb, 
and a score of 1 indicates complete favor of the contralateral forelimb. As expected, low 
asymmetry scores followed the unilateral 6-OHDA infusion (Day 0). These low post-lesion 
scores are relatively unaffected by levodopa treatment (Days 21-27). LUA scores finally begin to 
increase during the Saline 2 period (Days 28-34), which indicates that the lesion has begun to 
stabilize and that the rats may be learning to compensate for the lesion. Error bars indicate 
standard error in the mean. Hash marks indicate a significant difference between 0.5 (perfectly 
symmetric score) and every subsequent session, including all the post-lesion period and all three 
drug periods. 
 
  
TIME-COURSE OF MOTOR DEFICITS  29 
	  
Appendix 
Anti-Tyrosine Hydroxylase Histology Images. 
Animals with effective dorsolateral lesions of the striatum – Included in study 
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Animals with weak or inappropriate dorsolateral lesions of the striatum – Excluded 
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